Print

OpGen Technologies, Inc. Announces Argus Optical Mapping System Purchase by Wellcome Trust Sanger Institute  
1/7/2011 9:27:04 AM

(BUSINESS WIRE)--OpGen, Inc., a commercial phase genomics and DNA analysis company, today announced that the Wellcome Trust Sanger Institute has purchased an Argus™ Optical Mapping System in order to reduce the time and cost of whole genome sequence assembly.
//-->